Yayın:
Studies on controlled release dimenhydrinate from matrix tablet formulations

dc.contributor.authorGenç, Lütfı
dc.contributor.authorBilaç, Hadi
dc.contributor.authorGüler, E.
dc.date.accessioned2025-11-13T10:30:52Z
dc.date.issued1999-12-01
dc.identifier.doihttps://doi.org/10.1016/s0031-6865(99)00017-5
dc.identifier.endpage49
dc.identifier.issn0031-6865
dc.identifier.issue1
dc.identifier.openalexW2000179103
dc.identifier.startpage43
dc.identifier.urihttps://hdl.handle.net/11421/4389
dc.identifier.urihttps://doi.org/10.1016/s0031-6865(99)00017-5
dc.identifier.volume74
dc.language.isoen
dc.relation.ispartofPharmaceutica Acta Helvetiae
dc.rightsrestrictedAccess
dc.subjectMagnesium stearate
dc.subjectFriability
dc.subjectGranulation
dc.subjectDissolution
dc.subjectDosage form
dc.subjectLubricant
dc.subjectChromatography
dc.subjectMaterials science
dc.subjectPolymer
dc.subjectChemistry
dc.subjectComposite material
dc.subjectEthyl cellulose
dc.subjectOrganic chemistry
dc.subject.sdg6
dc.titleStudies on controlled release dimenhydrinate from matrix tablet formulations
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5049294391
local.authorid.openalexA5047328716
local.authorid.openalexA5004207725

Dosyalar

Koleksiyonlar